Cell Therapy Media Market
Cell Culture Consumables and Cell Culture Media Market (2nd Edition): Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Product (Culture Media, Kits, Cell Culture Reagents and Extracellular Matrices), Type of Cell Therapy (T-Cell Therapy, Stem Cell Therapy, Dendritic Cell Therapy and NK Cell Therapy), Scale of Operation (Clinical and Commercial), Type of End User (Industry and Non-Industry) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa (MENA) and Latin America)
-
Lowest Price Guaranteed
-
Pages
250 -
Last Updated
September 2026 -
View Count
19253 -
Cell Therapy Media Market Overview
The global cell therapy media market, valued at USD 1.6 billion in 2025, is projected to reach USD 1.8 billion in 2026 and USD 4.5 billion by 2035, with a 10.6% CAGR during the forecast period 2026 to 2035.
 |
To learn more about this report, request a free sample copy
The therapeutic approach involving the injection of healthy cells in the human body to replace the diseased / non-functioning cells, in order to regulate certain functions, is referred to as cell therapy. In the past few years, this therapeutic approach has emerged as one of the key areas of interest in the healthcare sector, given its ability to treat diseases which were previously considered untreatable. Consequently, driven by the benefits offered by cellular therapies and recent approvals granted by regulatory authorities, the demand for cellular therapies has increased considerably; this has led to a rise in the requirement of cell therapy raw materials. Specifically, cell therapy consumables refer to materials that are used in the manufacturing of cell therapies. It is worth mentioning that the selection of cell therapy consumables, specifically the cell culture media and supplements, is a crucial step in cell therapy manufacturing as they directly impact the potency and safety of the final product. In this cell culture consumables and cell culture media market report, we have considered the four predominant types of consumables applicable to cell therapy, namely cell culture media, media kits providing culture media along with the necessary media supplements, cell culture reagents and extracellular matrices.
Cell Therapy Media Market: Key Insights
The "Cell Culture Consumables and Cell Culture Media Market (2nd Edition): Industry Trends and Global Forecasts, till 2035" report features an extensive study of the current market landscape, market size and the likely future potential of the cell culture media (supplied alone or in kits as a combination with cell growth supplements), cell culture reagents and ECM market, over the forecast period. It highlights the efforts of several stakeholders engaged in this rapidly emerging segment of the cell therapy industry. Key inclusions of the cell therapy consumables and cell culture media market report are briefly discussed below.
Please click on the thumbnail images to expand and view the details.
 |
 |
 |
Cell Culture Media Market Drivers: Growing Demand for Cell Therapies
Since the development of the first cell therapy, this therapeutic segment has garnered significant attention from researchers and medical practitioners. This can be attributed to the fact that cell therapies have been demonstrated to possess a vast potential in the treatment of rare disorders, which were previously considered incurable. The popularity of this therapeutic class of products can also be validated from the fact that, since 2019, more than 1,000 clinical trials focused on cell therapies have been initiated. It is also worth mentioning that over 35 cell and gene therapies have already been commercialized, across various geographical locations, till date. Notable examples of recently approved cell therapies include (in reverse chronological order) Breyanzi® (June 2022), Carvykti™ (February 2022) and Abecma® (March 2021).
Need for High-Quality Cell Culture Consumables for Cell Therapy
Driven by the rise in popularity of cell therapies, there is a growth in demand for cell culture media, cell culture reagents and surfaces that support their production. It is worth mentioning that, amidst the increasing demand for such products, there is a rise in stringency from regulatory authorities to ensure that the quality of raw materials is good. Therefore, to meet the industry needs, cell therapy manufacturers are actively adopting serum free and xeno free products, which are known to reduce the risk of batch-to-batch variability.
Please click on the thumbnail images to expand and view the details.
 |
 |
 |
Role of Cell Therapy Consumables and Cell Culture Media in Commercialization of Cell Therapies
Currently, the marketed cell-based therapies are exorbitantly priced. Even though, with the introduction of automation technologies in cell therapy bioprocessing, the cost and time required for development of such products has reduced significantly, there is still a considerable scope of improvement to make these therapies affordable.
In this context, it is worth mentioning that consumables, including media, reagents and matrices, currently constitute nearly 25% of the overall cost of cell therapy manufacturing. Optimization of raw materials, by streamlining the production processes, can help mitigate wastage and further reduce the manufacturing cost. Moreover, for commercial applications, it is crucial to obtain consistent outcomes during the manufacturing process. Cell culture media, with chemically defined formulation, provides enhanced consistency for production purposes.
Current Market Landscape of Cell Culture Media, Cell Culture Reagents and Other Consumables for Cell Therapy
The cell therapy consumable providers market landscape features more than 80 companies, which claim to possess the necessary expertise for manufacturing of over 450 research and / or therapeutic grade raw materials. Some of these players also claim to have developed GMP certified facilities for the production of consumables, which are intended to be used for a range of human cells, including T-cells, stem cells, dendritic cells and NK cells. Subsequently, cell culture media market represents majority share (57%) of consumables offered, followed by the share captured by media and supplement kits (26%), extracellular matrices (14%) and cell culture reagents (3%). The ancillary materials offered by these companies are available in various volumes and can be utilized for numerous functions, such as cell proliferation, cell differentiation and cell isolation. Recent developments in cell culture consumables and cell culture media industry indicate that participants are actively expanding their capacity and product portfolio in order to accommodate the current and anticipated demand for cell therapies.
Please click on the thumbnail images to expand and view the details.
 |
 |
 |
Cell Culture Media Market Trends
In recent years, there has been a considerable rise in regulatory stringency as well as awareness related to disadvantages of using animal-based medica formulations, in the cell therapy domain. Specifically, animal-based media pose an undesirable risk of transfecting infectious agents. This has resulted in a shift towards the higher adoption of chemically defined, animal-component free (serum-free and xeno-free) media, in the cell culture media market. It is worth mentioning that, currently, majority of the cell culture media are being used for the development of stem cell therapies, followed by those intended for T-cell therapies.
Cell Therapy Consumables Market Drivers: Approval of Cell Therapies and Increase in the Number of Clinical Trials
One of the key drivers of the investments in this market is the success of previously commercialized cell therapies. More than USD 35 billion has already invested in cell therapy industry by private investors. In the last few years, cell therapies have offered a relatively more reliable approach for the treatment of rare diseases. According to a study published in 2019, the prevalence rate of rare diseases is about 263 to 446 million individuals, at any point of time. This necessitates the need for more such life-saving therapies. It is worth highlighting that, by 2030, close to 60 cell and gene therapies are anticipated to receive regulatory approval, further expanding the opportunities associated within the market. These factors will, in turn, lead to a surge in the requirement for quality consumables, driving significant market growth of the cell culture media industry.
Market Size of the Cell Culture Consumables and Cell Culture Media Market
Driven by the indubitably rising need for cell therapies, the market for cell culture media and other consumables for cell therapy manufacturing is anticipated to grow at a CAGR of 10.6%, during the forecast period, till 2035. Specifically, in terms of scale of operation, the demand for consumable products for commercial operations are expected to expand rapidly with the anticipated approval of numerous cell therapies. Additionally, it is worth highlighting that more than 80% of the current cell culture consumables and cell culture market share is captured by players based in North America and Asia-Pacific.
Key Companies in the Cell Culture Consumables and Cell Culture Media Market
Examples of key companies engaged in this industry (which have also been captured in this report) include BD Biosciences, Bio-Techne, CellGenix, Corning, Irvine Scientific (Acquired by FUJIFILM), Lonza, Miltenyi Biotech, Sartorius, STEMCELL Technologies and Thermo Fisher Scientific. This cell culture consumables and cell culture media market analysis includes and easily searchable excel database of all the companies engaged in this industry, worldwide.
Recent Developments in Cell Culture Consumables and Cell Culture Media Market
Several recent developments have taken place in the field of cell therapy consumables. Some of these recent initiatives have been mentioned below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that we have outlined in our analyses.
- In August 2026, Lonza launched its Rapid Media Prototyping Service (RaMP), providing biopharmaceutical developers with custom liquid and powder media for early process development.
- In August 2026, AuctuCel launched AuctuPrime, a chemically defined cell therapy medium developed with Sperikon. The formulation is designed to eliminate animal serum and donor-derived human platelet supplements from cell therapy manufacturing, targeting improved consistency, reduced biological variability and greater scalability for advanced therapy production in Singapore and Malaysia.
- In August 2026, AuctuCel entered into a collaboration with JCBIO where JCBIO will distribute AuctuCel’s cell therapy culture media in South Korea, expanding the company beyond Southeast Asia.
- In July 2026, RoosterBio collaborated with Applied StemCell in order to develop and commercialize scalable iPSC-based bioprocess solutions. The collaboration combines Applied StemCell’s GMP-compatible iPSC technology with RoosterBio’s engineered media, reagents and scalable manufacturing systems, creating an integrated workflow intended to support advanced therapy development from research through clinical manufacturing.
- In July 2026, RoosterBio entered into distribution agreement with Qkine, creating a single-vendor source for cells, bioprocess media and recombinant growth factors. RoosterBio will distribute Qkine’s research-use-only growth factors, cytokines and complex proteins, expanding access for cell and exosome therapy developers while supporting translation from research toward GMP manufacturing.
Scope of the Cell Culture Media Market Report
The study presents an in-depth analysis of the various firms / organizations that are engaged in this industry, across different segments as defined in the below table:
| Key Report Attributes | Details | |
|
Forecast Period |
|
|
| Current Market Size |
|
|
| Market Size 2035 |
|
|
|
CAGR |
|
|
| Type of Product |
|
|
| Type of Cell Therapy |
|
|
|
Scale of Operation |
|
|
|
Type of End-User |
|
|
|
Key Geographical Regions |
|
|
|
Key Companies Profiled |
|
|
|
Customization Scope |
|
|
|
PowerPoint Presentation (Complimentary) |
|
|
|
Excel Data Packs (Complimentary) |
|
|
The market research report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry, across different regions. Amongst other elements, the market report includes:
- A preface providing an introduction to the full report, Cell Culture Consumables and Cell Culture Media Market (2nd Edition), till 2035.
- An executive summary of the insights captured during our research, offering a high-level view on the current state of the cell culture consumables and cell culture media market and its likely evolution in the mid-long term.
- A general introduction to cell therapies, including details related to the development and manufacturing of such therapeutics products, with addition focus on role of raw materials in cell therapy production. It further provides a brief overview of the different types of cell culture consumables for cell therapies and key challenges associated with their development.
- A detailed assessment of the overall market landscape of companies offering cell culture consumables and cell culture media, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of product (kits, media, reagents and extracellular matrices), number and location of consumable facilities, accreditations received, type of end-user (industry and non-industry), cell culture media compatibility (serum free media, xeno free media and both), type of cell therapy (T-cell therapies, stem cell therapies, NK cell therapies, dendritic cell therapies and others), type of function (cell proliferation, cell expansion, cell differentiation, cell activation, cell isolation, cell attachment), kit components (supplements / reagents, growth / induction medium, expansion medium, differentiation medium and others), type of ECM coating (laminin, fibronectin, vitronectin, basement membrane extract and others), type of formulation (powder, liquid, pre-coated cultureware), shelf life (6-12 months, 13-18 months, 19-24 months and 25-36 months), scale of operation (discovery, preclinical, clinical and commercial), application area (research use and therapeutic use), storage temperature (refrigerated, frozen, ultra-low and room temperature), as well as volume of media, reagents and extracellular matrices.
- A detailed competitiveness analysis of companies operating in the cell culture consumable and cell culture media market (kits, media, reagents and extracellular matrices) based on supplier strength (in terms of years of experience and company size), portfolio strength (considering media compatibility, number of unique type of cell therapy, application area, product manufacturing practices and number of consumable facilities) and number of products offered.
- A detailed brand positioning analysis of prominent industry players (shortlisted on the basis of strength of service portfolio), highlighting the current perceptions regarding their proprietary brands across different consumable classes.
- Elaborate profiles of key companies in cell therapy consumables and cell culture media market (shortlisted on the basis of portfolio strength and number of products offered); each profile includes a brief overview of the company, along with information on its cell therapy consumables focused product portfolio, consumable facilities, recent developments and an informed future outlook.
- An analysis of recent developments within the cell culture consumables and cell culture media market, highlighting information on several partnerships and collaborations, mergers and acquisitions, and expansion initiatives that have taken place within this industry, since 2016.
- A list of over 250 cell therapy developers that are anticipated to partner with cell culture consumables and cell culture media providers; these companies have been shortlisted based on several relevant parameters, such as developer strength (which takes into account a company’s size and its experience in this field), pipeline strength and maturity (based on the number of pipeline drugs and affiliated stage of development), and availability of other cell therapy capabilities.
- A proprietary Roots Analysis competitive pricing framework, which analyzes the competitive position of various companies engaged in cell culture consumables and cell culture media market, by taking into consideration the prices and features of their consumable offerings (such as media and extracellular matrices). In addition, it presents an equation devised to calculate the likely price of cell therapy consumables based upon their characteristics.
- An informed estimate of the annual demand for cell culture consumables and cell culture media (in terms of volume of media required for total number of cells), based on scale of operation and key geographical regions.
- An in-depth discussion on the upcoming trends and future growth opportunities within the cell culture consumables and cell culture media market, featuring details related to the significance of automation in cell therapy manufacturing processes and benefits of single use technologies for production of cell therapies.
One of the key objectives of the market report was to estimate the current opportunity and the future growth potential of the cell culture consumables and cell culture media market over the coming years. We have provided an informed estimate on the likely evolution of the market for the forecast period, till 2035. Our year-wise projections of the current and forecasted opportunity have been further segmented based on relevant parameters, such as type of product (kits, media, reagents and extracellular matrices), type of cell therapy (t-cell therapies, stem cell therapies, dendritic cell therapies and NK cell therapies), scale of operation (clinical and commercial), type of end-user (industry and non-industry) and key geographical regions (North America, Europe, Asia-Pacific, MENA and Latin America). In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, portraying the conservative, base and optimistic scenarios of the industry’s evolution.
The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders in cell culture consumables and cell culture media industry. The market report features detailed transcripts of interviews held with the following individuals:
- Vice President, Business Development, Small Company, US
- Director R&D, Cell Culture and Immunology, Large Company, India
- Chief Operating Officer, Small Company, US
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.